|
|
Article: FDA Approves GlaxoSmithKline's PEDIARIX(TM) First U.S. Combination Vaccine to Protect Infants Against Five Diseases.
- Article from:
- PR Newswire
- Article date:
- December 16, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New Vaccine Results In Up To Six Fewer Injections For Infants
GlaxoSmithKline announced today that its combination vaccine, PEDIARIX(TM)[Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined], received approval from the U.S. Food and Drug Administration (FDA) to be given to infants at 2, 4 and 6 months of age for the prevention of diphtheria, tetanus, pertussis, hepatitis B, and polio.* PEDIARIX is the first five-in- one U.S.-licensed vaccine to offer protection against five serious diseases in a three-dose vaccination series. This combination vaccine results in up to six fewer ...